Reduction In Mortality For Children With Severe Langerhans Cell Histiocytosis Shown In Clinical Trial

A new international study finds that introducing an increased intensity of chemotherapy in children with severe Langerhans cell histiocytosis (LCH) can reduce the mortality rate for this disorder by as much as 20 percent when the patient demonstrates a rapid response to such treatment.

More: continued here

Filed under: Cancer on March 3rd, 2008